Decision and Order: Gene M. Koop, DDS
DEA issued a final order denying Gene M. Koop, DDS, a registration to handle controlled substances due to failure to comply with state and federal requirements, signaling increased scrutiny on dental practitioners and reinforcing the need for strict adherence to PDMP and recordkeeping rules.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on July 27, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Independent pharmacies, retail chains, compounding pharmacies, long-term-care pharmacies that dispense controlled substances for dental practices or have DEA registrations. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Ongoing; immediate review of current practices recommended.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
DEA denied a controlled substance registration to a dentist, emphasizing that non-compliance with state PDMP, recordkeeping, and diversion prevention can result in registration denial or revocation.
Who it affects
Independent pharmacies, retail chains, compounding pharmacies, long-term-care pharmacies that dispense controlled substances for dental practices or have DEA registrations.
What you must do
Review and strengthen compliance with PDMP checks, suspicious order monitoring, and recordkeeping for all controlled substance prescriptions, especially those from dental practitioners.
Deadline
Ongoing; immediate review of current practices recommended.
Source: https://www.federalregister.gov/public-inspection/2026-15201/decision-and-order-gene-m-koop-dds
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- Decision and Order: Kerri Zavota, DVM
- GLP-1 Drugs: Ohio Board of Pharmacy Issues FAQs for Compounders - The National Law Review
- US-CONGRESS S5043: Secure Drug Supply Chain Act of 2026
- Francis Esteban Matos: Final Debarment Order
- Ohio Board of Pharmacy Proposes Strengthened Disciplinary Actions: What Pharmacies Need to Know - Buchanan Ingersoll & Rooney PC